Epigenetic changes in poultry due to reprogramming of the gut microbiota
Oral GLP-1 biologics (e.g., in early development at Biora and Viking) or small molecule GLP-1R agonists (e.g., Structure Therapeutics), will further improve patient adherence and facilitate clinical uptake of these medications
Research supports that Glutathione decreases muscle damage, improves recovery time, and supports the metabolism of less fat production to better muscle development
Glucagon receptor activation increases thermogenesis and fat oxidation, meaning your body burns through stored energy at a higher rate than it would on Semaglutide or Tirzepatide alone
While both medications are GLP-1 receptor agonists, Tirzepatide also activates a second receptor (GIP), which may provide additional metabolic benefits
Clinical trials have shown that semaglutide can lead to significant loss in body weight